Reducing Adult Inpatients Anxiety With Virtual Reality Meditation
NCT ID: NCT06234254
Last Updated: 2025-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
200 participants
INTERVENTIONAL
2026-06-01
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality for Anxiety Management in Mechanically Vented Patients
NCT03169374
Virtual Reality and Relaxation for the Treatment of Generalized Anxiety Disorders: a Comparative Study With Standard Relaxation
NCT02571790
Medical Mindfulness: Virtual Reality Mindfulness Therapy for Anxiety and Pain Management in Patients With Acute and Chronic Pain
NCT04534101
Virtual Reality as Anxiety Management Tool for Generalized Anxiety Disorder
NCT00602212
A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study
NCT04622527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Reality
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Virtual Reality headset with calming scenery
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Control
No intervention (i.e. virtual reality headset) will be applied to the participant.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality headset with calming scenery
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized at Stanford Health Care
* english-speaking
Exclusion Criteria
* current nausea
* visual problems or currently using corrective glasses that are incompatible with the virtual reality headset
* a history of severe motion sickness
* a history of seizures cause by flashing light
* clinically unstable or require immediate/urgent intervention
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Caruso
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Caruso
Role: STUDY_DIRECTOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford Health Care (SHC)
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
73841
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.